Background: In cardiogenic shock (CS) patients requiring temporary mechanical circulatory support (tMCS), assessing cardiac recovery vs the need for heart replacement therapy is critical. We developed and validated a new clinical score aimed at predicting successful tMCS liberation.
Methods: A cohort of 80 CS patients treated with Impella support between January 2018 and December 2020 was analyzed.